PMID- 24356648 OWN - NLM STAT- MEDLINE DCOM- 20141124 LR - 20140319 IS - 1423-0194 (Electronic) IS - 0028-3835 (Linking) VI - 98 IP - 4 DP - 2013 TI - Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1. PG - 290-8 LID - 10.1159/000357779 [doi] AB - AIM: To assess the characteristics and long-term outcome after surgery in patients with multiple endocrine neoplasia type 1 (MEN1)-associated insulinoma. METHODS: Retrospective analysis of prospectively collected data of MEN1 patients with organic hyperinsulinism at a tertiary referral center. RESULTS: Thirteen (17%) of 74 patients with MEN1 had organic hyperinsulinism. The median age at diagnosis was 27 (range 9-48) years. In 7 patients insulinoma was the first manifestation of the syndrome. All patients had at least one pancreatic neuroendocrine neoplasm (pNEN) upon imaging, including CT, MRI or endoscopic ultrasonography. Seven patients had solitary lesions upon imaging, 4 patients had one dominant tumor with coexisting multiple small pNENs, and 2 patients had multiple lesions without dominance. Eight patients had limited resections (1 segmental resection, 7 enucleations), 4 subtotal distal pancreatectomies, and 1 patient a partial duodenopancreatectomy. There was no postoperative mortality. Six patients experienced complications, including pancreatic fistula in 5 patients. Pathological examination revealed median three (range 1-14) macro-pNENs sized between 6 and 40 mm, and a total of 14 potentially benign insulinomas were detected in the 13 patients. After median follow-up of 156 months, only 1 patient developed recurrent hyperinsulinism after initial enucleation. Twelve patients developed new pNENs in the pancreatic remnant and 4 patients underwent reoperations (3 for metastatic ZES, 1 for recurrent hyperinsulinism). One of 5 patients with an initial extended pancreatic resection developed insulin-dependent diabetes mellitus. CONCLUSION: Enucleation and limited resection provide long-term cure for MEN1 insulinoma in patients with solitary or dominant tumors. Subtotal distal pancreatectomy should thus be preserved for patients with multiple pNENs without dominance given the risk of exocrine and endocrine pancreas insufficiency in the mostly young patients. CI - (c) 2013 S. Karger AG, Basel. FAU - Bartsch, Detlef K AU - Bartsch DK AD - Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany. FAU - Albers, Max AU - Albers M FAU - Knoop, Richard AU - Knoop R FAU - Kann, Peter H AU - Kann PH FAU - Fendrich, Volker AU - Fendrich V FAU - Waldmann, Jens AU - Waldmann J LA - eng PT - Journal Article DEP - 20131217 PL - Switzerland TA - Neuroendocrinology JT - Neuroendocrinology JID - 0035665 SB - IM MH - Adolescent MH - Adult MH - Child MH - Diabetes Mellitus, Type 1/etiology MH - Female MH - Follow-Up Studies MH - Humans MH - Insulinoma/pathology/*surgery MH - Male MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/pathology/*surgery MH - Neoplasm Recurrence, Local/surgery MH - *Pancreatectomy/adverse effects/methods MH - Pancreatic Fistula/etiology MH - Pancreatic Neoplasms/pathology/*surgery MH - Prospective Studies MH - Reoperation MH - Retrospective Studies MH - Tertiary Care Centers MH - Time Factors MH - Treatment Outcome MH - Young Adult EDAT- 2013/12/21 06:00 MHDA- 2014/12/15 06:00 CRDT- 2013/12/21 06:00 PHST- 2013/08/23 00:00 [received] PHST- 2013/12/06 00:00 [accepted] PHST- 2013/12/21 06:00 [entrez] PHST- 2013/12/21 06:00 [pubmed] PHST- 2014/12/15 06:00 [medline] AID - 000357779 [pii] AID - 10.1159/000357779 [doi] PST - ppublish SO - Neuroendocrinology. 2013;98(4):290-8. doi: 10.1159/000357779. Epub 2013 Dec 17.